Compositions containing tucaresol or its analogs
US11857522B2 · kind B2 · utility
1Cited by
51References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2021 |
| Grant date | Jan 2, 2024 |
| Priority date | — |
| Expiry date | Sep 14, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions including a compound of formula (I) for treating cancer. Some embodiments relate to methods of treating cancer by co-administering a compound of formula (I) and one or more immune checkpoint inhibitor to a subject in need thereof. Some embodiments relate to methods of treating cancer by co-administering a compound of formula (I) and plinabulin to a subject in need thereof. Some embodiments relate to methods of providing co-stimulation of T-cell activation against cancer by co-administering a compound of formula (I), one or more immune checkpoint inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.